Navigation Links
Avista Capital Partners Announces a Majority Investment in Vertical Pharmaceuticals and Trigen Laboratories
Date:12/16/2013

30 years of operational, marketing, commercial development, and sales experience with international pharmaceutical companies. Most recently, he was President and Chief Executive Officer of Fougera Pharmaceuticals Inc., the dermatology-focused pharmaceuticals company that was spun off from Nycomed A/S in 2011 and sold to Sandoz, the generics division of Novartis, in July 2012. Prior to leading Fougera, Mr. Markison served as Chairman and Chief Executive Officer of King Pharmaceuticals before it was acquired by Pfizer.

Mr. Markison said, "I am thrilled to be joining Vertical / Trigen as Executive Chairman. Having led other specialty pharmaceutical companies through various phases of development, I am very excited about the Company's potential to increase market share with existing products while pursuing attractive add-on opportunities to accelerate growth. I look forward to working with the Vertical / Trigen team to support these efforts."

David Burgstahler, Partner and President of Avista, said, "We believe Vertical / Trigen is a strong platform on which to build a diversified North American pharmaceuticals business.  The Company's existing product footprint and development pipeline can be leveraged in combination with product acquisition and licensing opportunities to create a broader branded and generics company with a presence in a number of attractive therapeutic markets. Having worked closely with Brian Markison to grow other businesses in this space, we are confident that his expertise, along with all of the resources Avista has to offer, will help this talented management team take the Company to the next level."

Steven Squashic, CEO of Vertical / Trigen, said, "This is a great day for our company. Everyone at Vertical and Trigen should be proud of what we have achieved together over the last decade and excited about what we can accomplish in the
'/>"/>

SOURCE Avista Capital Partners
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. PLC Systems Secures Additional Financing For US Clinical Trials And General Working Capital
2. Genstar Capital Completes ERT Acquisition In A Take-Private Transaction
3. Savient Pharmaceuticals Receives Favorable Decision In Tang Capital Litigation
4. Intrepid Investment Bankers LLC Advises A-Med Health Care in the Sale of its Specialty Pharmacy Assets to Modern HC Pharmacy, Inc., a portfolio company of Altamont Capital Partners
5. Neuralstem Announces Exercise Of Entire Over-Allotment Option By Aegis Capital Corp.
6. Physicians Capital Investments, Physicians Capital Markets, and EDGE Realty Capital Markets announce a new strategic initiative
7. Savient Pharmaceuticals to Present at the 6th Annual Imperial Capital Global Opportunities Conference
8. Innophos To Present At 2012 KeyBanc Capital Markets Basic Materials & Packaging Conference
9. GP Strategies to Present at the BMO Capital Markets 12th Annual Back to School Education Conference
10. Raging Capital Calls On Taro Pharmaceutical Shareholders To Vote Against The Taro / Sun Pharma Merger
11. Masimo to Present at Lazard Capital Markets 9th Annual Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/31/2015)... and STAMFORD, Conn. , Aug. 31, ... Eisai Co., Ltd., and Purdue Pharma L.P. announced today ... for the development and commercialization of Eisai,s clinical candidate ... entering Phase III clinical development for the treatment of ... agreement, Eisai and Purdue Pharma will share the costs ...
(Date:8/31/2015)... Aug. 31, 2015 Research and Markets ... the "Prescription Pain Drugs - Including Opioid, ... Global Markets, Competitors and Opportunities: 2015 - 2020 ... Pain is defined as an ... or potential tissue damage. At some point, everyone ...
(Date:8/28/2015)... Fla. , Aug. 28, 2015  With the ... reaching deadlier heights, Jacksonville -based ... Philip Hemphill is helping to explain why fentanyl ... is approximately 40 to 50 times more potent than ... recreational users as heroin, the risk of death skyrockets. ...
Breaking Medicine Technology:Eisai and Purdue Pharma Enter Worldwide Collaboration to Develop and Commercialize Lemborexant 2Eisai and Purdue Pharma Enter Worldwide Collaboration to Develop and Commercialize Lemborexant 3Eisai and Purdue Pharma Enter Worldwide Collaboration to Develop and Commercialize Lemborexant 4Eisai and Purdue Pharma Enter Worldwide Collaboration to Develop and Commercialize Lemborexant 5Prescription Pain Drugs Including Opioid, Anticonvulsant, Injectable/ Inhaled, Topical/ Transdermal, Medical Marijuana - 2015-2020 Analysis and Forecasts 2Prescription Pain Drugs Including Opioid, Anticonvulsant, Injectable/ Inhaled, Topical/ Transdermal, Medical Marijuana - 2015-2020 Analysis and Forecasts 3Lakeview Health's Dr. Philip Hemphill Explains Why Heroin Addicts Are Now Dying of Fentanyl Overdoses 2
(Date:8/31/2015)... Pittsburgh, PA (PRWEB) , ... August 31, 2015 ... ... television than their peers may be at a greater risk for injury, potentially ... risk-taking behaviors, a University of Pittsburgh Graduate School of Public Health analysis discovered. ...
(Date:8/31/2015)... ... August 31, 2015 , ... Kognito , a ... their competencies in managing challenging conversations, announced today that Glenn Albright, Ph.D., the ... of Excellence for Psychological Health and Traumatic Brain Injury (DCoE) Summit taking ...
(Date:8/31/2015)... ... August 31, 2015 , ... On Saturday, May 30th, 2015, Best ... Adams County Fairgrounds in Mendon, IL. The purpose behind this concert was to raise ... neighboring town, Quincy. Best Drug Rehabilitation’s sponsorship of “Music with a Mission” helped with ...
(Date:8/31/2015)... , ... August 31, 2015 , ... ... e-Spirit to future-proof its content management system (CMS) and make website updates quicker ... Sports in making the websites of the Bundesliga (the German equivalent of the ...
(Date:8/31/2015)... ... 2015 , ... “My mother and husband use oxygen therapy and the tubing ... there could be a comfortable way to prevent the irritation, so I invented this.” ... a more secure way to anchor the cannula tubing used in oxygen therapy and ...
Breaking Medicine News(10 mins):Health News:Television Viewing Linked to Higher Injury Risk in Hostile People 2Health News:Television Viewing Linked to Higher Injury Risk in Hostile People 3Health News:Kognito’s Glenn Albright to Present at DCoE Summit 2Health News:2015 "Music With A Mission" Sponsor Best Drug Rehabilitation Releases Artist Compilation Video 2Health News:2015 "Music With A Mission" Sponsor Best Drug Rehabilitation Releases Artist Compilation Video 3Health News:On the Ball with FirstSpirit: German Soccer League (DFL Digital Sports) Opts for e-Spirit’s CMS 2Health News:InventHelp® Inventor Designs Nasal Cannula Ear Protector (AVZ-1217) 2
... Babies born to HIV-positive mothers and given the antiretroviral ... to prevent infection via breast-feeding are at high risk ... a team of researchers report. But the investigators highlight ... mother-to-child HIV transmission in breast-fed infants. , ...
... Corporation (NYSE: CBM ) is pleased ... Chief Executive Officer, will be presenting at the ... 9:00 a.m. PST at the Westin St. Francis, ... http://www.newscom.com/cgi-bin/prnh/20000613/CAMBREXLOGO )A live webcast of the presentation ...
... Jan. 5 Volcano Corporation,(Nasdaq: VOLC ), ... for the diagnosis and treatment of coronary and peripheral ... January 6, to,discuss its acquisition of Axsun Technologies, Inc., ... The teleconference call and webcast will begin ...
... Few things are as tiresome as house hunting and ... down pat. Tripping nimbly from one abode to another, ... than the original tumor. Although little has been known ... down roots, researchers at the Stanford University School of ...
... the U.S. each year have been exposed to alcohol or illicit ... the National Center on Substance Abuse and Child Welfare. If removed ... in foster care longer, and chances are very low that they ... led by Joseph P. Ryan, a faculty member in the School ...
... with Operation Smile to See the Difference, Make a ... through March 2009, Crest and Oral-B are encouraging people across the ... while also making a difference in children,s smiles worldwide. When ... difference in their smile. People can also make a ...
Cached Medicine News:Health News:Prolonged nevirapine in breast-fed babies prevents HIV infection but leads to drug-resistant HIV 2Health News:Prolonged nevirapine in breast-fed babies prevents HIV infection but leads to drug-resistant HIV 3Health News:Reminder: Volcano Corporation Schedules Conference Call, Webcast to Discuss Axsun Transaction 2Health News:'Relocation' plan of metastatic cancer cells uncovered by Stanford researchers 2Health News:'Recovery coaches' effective in reducing number of babies exposed to drugs 2Health News:'Recovery coaches' effective in reducing number of babies exposed to drugs 3Health News:Crest and Oral-B Challenge America to See The Difference in Their Smile and Make A Difference in Children's Smiles Around the World 2Health News:Crest and Oral-B Challenge America to See The Difference in Their Smile and Make A Difference in Children's Smiles Around the World 3Health News:Crest and Oral-B Challenge America to See The Difference in Their Smile and Make A Difference in Children's Smiles Around the World 4
Low Profile Design for Precise Anchor Placement...
... utilizes a suprapubic approach to treat ... urethral hypermobility and/or intrinsic sphincter deficiency ... needles and a self-fixating sling with ... for intra-operative tension refinement without mesh ...
... The Uretex® Trans-Obturator ... excellent tension-free, self-anchoring support ... The polypropylene mesh maintains ... flat placement under the ...
... Delivers the durability of natural ... benefits of ingrowth and natural ... or exceeds all applicable state ... Allograft Tissue also reduces OR ...
Medicine Products: